AD is characterized by a long preclinical stage noted by the deposition of amyloid plaques and tau tangles, followed by a destructive cascade of neurodegeneration leading to mild cognitive impairment and progression to dementia (3, 4). This evidence concerns the gene MAPT and Alzheimer disease.